BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

741 related articles for article (PubMed ID: 23648198)

  • 1. Microbicidal properties of Leukocyte- and Platelet-Rich Plasma/Fibrin (L-PRP/L-PRF): new perspectives.
    Cieslik-Bielecka A; Dohan Ehrenfest DM; Lubkowska A; Bielecki T
    J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):43S-52S. PubMed ID: 23648198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Bielecki T; Jimbo R; Barbé G; Del Corso M; Inchingolo F; Sammartino G
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1145-52. PubMed ID: 21740377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro.
    Schär MO; Diaz-Romero J; Kohl S; Zumstein MA; Nesic D
    Clin Orthop Relat Res; 2015 May; 473(5):1635-43. PubMed ID: 25690170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Leukocyte-platelet Rich Fibrin, A Novel Biomaterial.
    Madurantakam P; Yoganarasimha S; Hasan FK
    J Vis Exp; 2015 Sep; (103):. PubMed ID: 26485642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF).
    Dohan Ehrenfest DM; Rasmusson L; Albrektsson T
    Trends Biotechnol; 2009 Mar; 27(3):158-67. PubMed ID: 19187989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of leukocytes from L-PRP/L-PRF in wound healing and immune defense: new perspectives.
    Bielecki T; Dohan Ehrenfest DM; Everts PA; Wiczkowski A
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1153-62. PubMed ID: 21740376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth factor and catabolic cytokine concentrations are influenced by the cellular composition of platelet-rich plasma.
    Sundman EA; Cole BJ; Fortier LA
    Am J Sports Med; 2011 Oct; 39(10):2135-40. PubMed ID: 21846925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of platelet concentrates: platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in bone reconstruction prior to dental implant surgery].
    Baeyens W; Glineur R; Evrard L
    Rev Med Brux; 2010; 31(6):521-7. PubMed ID: 21290856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria.
    Davis VL; Abukabda AB; Radio NM; Witt-Enderby PA; Clafshenkel WP; Cairone JV; Rutkowski JL
    J Oral Implantol; 2014 Aug; 40(4):511-21. PubMed ID: 25106017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autologous platelet concentrates in maxillofacial regenerative therapy.
    Chou TM; Chang HP; Wang JC
    Kaohsiung J Med Sci; 2020 May; 36(5):305-310. PubMed ID: 32052598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 2: Bone graft, implant and reconstructive surgery.
    Simonpieri A; Del Corso M; Vervelle A; Jimbo R; Inchingolo F; Sammartino G; Dohan Ehrenfest DM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1231-56. PubMed ID: 21740370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applications and limits of platelet-rich plasma in sports related injuries.
    Stanco D; Vigano' M; Croiset SJ; De Girolamo L
    J Biol Regul Homeost Agents; 2012; 26(2 Suppl 1):53S-61S. PubMed ID: 23648199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial effect of platelet-rich plasma and platelet-rich fibrin.
    Badade PS; Mahale SA; Panjwani AA; Vaidya PD; Warang AD
    Indian J Dent Res; 2016; 27(3):300-4. PubMed ID: 27411660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of leukocyte- and platelet-rich plasma gel (L-PRP gel) in treating osteomyelitis in a rabbit model.
    Li GY; Yin JM; Ding H; Jia WT; Zhang CQ
    J Orthop Res; 2013 Jun; 31(6):949-56. PubMed ID: 23280538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte presence does not increase microbicidal activity of Platelet-rich Plasma in vitro.
    Mariani E; Canella V; Berlingeri A; Bielli A; Cattini L; Landini MP; Kon E; Marcacci M; Di Matteo B; Filardo G
    BMC Microbiol; 2015 Jul; 15():149. PubMed ID: 26223356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-PRP/L-PRF in esthetic plastic surgery, regenerative medicine of the skin and chronic wounds.
    Cieslik-Bielecka A; Choukroun J; Odin G; Dohan Ehrenfest DM
    Curr Pharm Biotechnol; 2012 Jun; 13(7):1266-77. PubMed ID: 21740368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro.
    He L; Lin Y; Hu X; Zhang Y; Wu H
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov; 108(5):707-13. PubMed ID: 19836723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shedding light in the controversial terminology for platelet-rich products: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), platelet-leukocyte gel (PLG), preparation rich in growth factors (PRGF), classification and commercialism.
    Dohan Ehrenfest DM; Bielecki T; Del Corso M; Inchingolo F; Sammartino G
    J Biomed Mater Res A; 2010 Dec; 95(4):1280-2. PubMed ID: 20925082
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial properties of single-donor-derived, platelet-leukocyte fibrin for fistula occlusion: An in vitro study.
    Wu X; Ren J; Yuan Y; Luan J; Yao G; Li J
    Platelets; 2013; 24(8):632-6. PubMed ID: 23402660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane.
    Dohan Ehrenfest DM; Pinto NR; Pereda A; Jiménez P; Corso MD; Kang BS; Nally M; Lanata N; Wang HL; Quirynen M
    Platelets; 2018 Mar; 29(2):171-184. PubMed ID: 28437133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.